ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome.

Poor prognosis of malignant gliomas is primarily attributed to their highly invasive nature. Despite the identification of new biomarkers and molecular targets for the improvement of the diagnosis, prognosis and treatment of glioma, the overall prognosis of the disease remains poor. This study is the first to show the significant upregulation of ARK5 paraffin-embedded archival glioma biopsies compared with those in adjacent non-cancerous brain tissues. Statistical analysis suggests that the upregulation of ARK5 correlates with the World Health Organization grade of glioma (P<0.001) and that patients with a high ARK5 level exhibit shorter survival time (P<0.01). In addition, ARK5 can promote glioma cell invasion by regulating cytoskeleton rearrangement and matrix metalloproteinase activation. ARK5 knockdown was found to reduce brain invasion in a glioma xenograft mouse model. Our results strongly suggest that ARK5 represents a novel and valuable biomarker to aid in the prediction of patient prognosis and is a potential therapeutic target against glioma.

[1]  J. Testa,et al.  AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. , 2001, Cancer research.

[2]  P. Caroni,et al.  Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase , 1998, Nature.

[3]  John S. Condeelis,et al.  Cofilin Promotes Actin Polymerization and Defines the Direction of Cell Motility , 2004, Science.

[4]  H. Esumi,et al.  Involvement of Transforming Growth Factor-β1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation* , 2005, Journal of Biological Chemistry.

[5]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[6]  M. Weller,et al.  Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. , 2007, Neuro-oncology.

[7]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[8]  B. Karlan,et al.  Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. , 2003, Cancer research.

[9]  J. S. Rao,et al.  Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.

[10]  R. Niu,et al.  Reduction of Akt2 inhibits migration and invasion of glioma cells , 2009, International journal of cancer.

[11]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[12]  Libing Song,et al.  Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. , 2010, Cancer research.

[13]  J. Roman,et al.  Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. , 2011, The Journal of Biological Chemistry.

[14]  L. Stewart,et al.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.

[15]  Masahiro Yamamoto,et al.  Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration , 2005, The Journal of cell biology.

[16]  S. Green,et al.  GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis , 2006, Neurosurgery.

[17]  Gary M. Bokoch,et al.  Regulation of Actin Polymerization in Cell-free Systems by GTPγS and Cdc42 , 1997, The Journal of cell biology.

[18]  Kenneth M. Yamada,et al.  CrkI adapter protein modulates cell migration and invasion in glioblastoma. , 2003, Cancer research.

[19]  N. Navaratnam,et al.  Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1 , 2010, The EMBO journal.

[20]  K. Hoang-Xuan,et al.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Johnston,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0291 , 2022 .

[22]  H. Esumi,et al.  ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation , 2003, Oncogene.

[23]  A. Hall,et al.  Integrin-Mediated Activation of Cdc42 Controls Cell Polarity in Migrating Astrocytes through PKCζ , 2001, Cell.

[24]  Libing Song,et al.  Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival , 2008, Clinical Cancer Research.

[25]  P. Gao,et al.  Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. , 2005, Cancer research.

[26]  R. Glazer,et al.  Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. , 2001, Cancer research.

[27]  Charles Duyckaerts,et al.  The 2007 WHO classification of tumors of the central nervous system – what has changed? , 2008, Current opinion in neurology.

[28]  G. Das,et al.  Rictor regulates MMP‐9 activity and invasion through Raf‐1‐MEK‐ERK signaling pathway in glioma cells , 2011, Molecular carcinogenesis.

[29]  H. Esumi,et al.  Regulation of caspase-6 and FLIP by the AMPK family member ARK5 , 2004, Oncogene.

[30]  M. Mut,et al.  Protein kinase C-alpha-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion. , 2007, Cancer research.

[31]  H. Weiss,et al.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. , 2011, Cancer research.

[32]  H. Esumi,et al.  ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling , 2004, Molecular and Cellular Biology.

[33]  Yongping Wang,et al.  Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells , 2011, Oncogene.

[34]  Kyoung-Mee Kim,et al.  Prognostic role of p‐mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer , 2010, International journal of cancer.

[35]  B. Kemp,et al.  Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.

[36]  H. Esumi,et al.  Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein* , 2003, The Journal of Biological Chemistry.

[37]  H. Esumi,et al.  NDR2 Acts as the Upstream Kinase of ARK5 during Insulin-like Growth Factor-1 Signaling* , 2006, Journal of Biological Chemistry.

[38]  G. Fuller,et al.  Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. , 2000, Cancer research.

[39]  R. Niu,et al.  Akt2 is required for macrophage chemotaxis , 2009, European journal of immunology.

[40]  J. Condeelis,et al.  Spatial and Temporal Control of Cofilin Activity Is Required for Directional Sensing during Chemotaxis , 2006, Current Biology.

[41]  M. Kaminishi,et al.  ARK5 expression in colorectal cancer and its implications for tumor progression. , 2004, The American journal of pathology.

[42]  K. Kaibuchi,et al.  IQGAP1: a key regulator of adhesion and migration , 2005, Journal of Cell Science.

[43]  G. Laurent,et al.  Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis , 2012, Leukemia.

[44]  F. Zhan,et al.  ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma , 2005, Oncogene.

[45]  M. Weller,et al.  Inhibition of Epidermal Growth Factor Receptor Signaling Protects Human Malignant Glioma Cells from Hypoxia-Induced Cell Death , 2004, Cancer Research.

[46]  Michael E. Berens,et al.  Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.